Arginine and nutrition in renal disease

Journal of Renal Nutrition

Volumn 9, Issue 3, 1999, Pages 142-144

  Efron, David T ^a,b   Barbul, Adrian ^a,b  

^a SINAI HOSPITAL OF BALTIMORE   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84943010050     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1051-2276(99)90053-5     Document Type: Article

References (23)

1. Barbul, A, Arginine and immune function. Nutrition 6 (1990), 53–62.
2. Windmueller, HG, Spaeth, AE, Source and fate of circulating citrulline. Am J Physiol 241 (1981), E473–E480.
3. Wu, G, Morris, SM, Arginine metabolism: Nitric oxide and beyond. Biochem J 336 (1998), 1–17.
4. Barbul, A, Wasserkrug, HL, Seifter, E, et al. Immunostimulatory effects of arginine in normal and injured rats. J Surg Res 29 (1980), 228–235.
5. Barbul, A, Wasserkrug, HL, Sisto, DA, et al. Thymic stimulatory actions of arginine. JPEN J Parenter Enteral Nutr 4 (1980), 446–449.
6. Barbul, A, Sisto, DA, HL, Wasserkrug, et al. Arginine stimulates lymphocyte immune response in healthy human beings. Surgery 90 (1981), 244–251.
7. Kirk, SJ, Barbul, A, Role of arginine in trauma, sepsis, and immunity. JPEN J Parenter Enteral Nutr 14 (1990), 226S–229S.
8. Efron, DT, Barbul, A, Modulation of inflammation and immunity by arginine supplements. Curr Opin Clin Nutr Metab Care 1 (1998), 531–538.
9. Jenkinson, CP, Grody, WW, Cederbaum, SD, Comparative properties of arginases. Comp Biochem Physiol B Biochem Mol Biol 114 (1996), 107–132.
10. Nathan, C, Xie, Q, Nitric oxide synthases: Rolls tolls and controls. Cell 78 (1994), 915–918.
11. Lortie, MJ, Novotny, WF, Peterson, OW, et al. Agmatine, a bioactive metabolite of arginine. J Clin Invest 97 (1997), 413–420.
12. Morrissey, JJ, Klahr, S, Effects of agmatine, an active metabolite of arginine metabolism, on the kidney. Nephrol Dial Transplant 11 (1996), 1217–1245.
13. Rosman, JB, ter Wee, PM, Meijer, S, et al. Prospective randomised trial of early dietary protein restriction in chronic renal failure. Lancet 2 (1984), 1291–1296.
14. Ihle, BU, Becker, GJ, Whitworth, JA, et al. The effect of protein restriction on the progression of renal insufficiency. N Engl J Med 321 (1989), 1773–1777.
15. Klahr, S, Levey, AS, Beck, GJ, et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. N Engl J Med 330 (1994), 877–884.
16. Ketteler, M, Border, WA, Noble, NA, Cytokines and L-arginine in renal injury and repair. Am J Physiol 267 (1994), F197–F207.
17. Reckelhoff, JF, Kellum, JA Jr, Racusen, LC, et al. Long-term dietary supplementation with L-arginine prevents age-related reduction in renal function. Am J Physiol 272 (1997), R1768–R1774.
18. Wolf, SC, Erley, CM, Kenner, ED, et al. Does L-arginine alter proteinuria and renal hemodynamics in patients with chronic glomerulonephritis and hypertension?. Clin Nephrol 43 (1995), S42–S46.
19. Andoh, TF, Gardner, MP, Bennett, WM, Protective effects of dietary L-arginine supplementation on chronic cyclosporine nephrotoxicity. Transplantation 64 (1997), 1236–1240.
20. Lubec, G, Aufricht, C, Amann, G, et al. Arginine reduces kidney collagen accumulation, cross-linking, lipid peroxidation, glycoxidation, kidney weight and albuminuria in the diabetic KK mouse. Nephron 75 (1997), 213–218.
21. Mendes Ribeiro, AC, Hanssen, H, Kiessling, K, et al. Transport of L-arginine and the nitric oxide inhibitor NG-monomethyl-L-arginine in human erythrocytes in chronic renal failure. Clin Sci (Colch) 93 (1997), 57–64.
22. Vallance, P, Leone, A, Calver, A, et al. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339 (1992), 572–575.
23. Ruilope, LM, Lahera, V, Rodicio, JL, et al. Participation of nitric oxide in the regulation of renal function: Possible role in the genesis of arterial hypertension. J Hypertens 12 (1994), 625–631.